Clinical Trial Update: Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating continuation of chemotherapy with pembrolizumab after progression on PD-1/PD-L1 inhibitors in metastatic non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: UNKNOWN